165 related articles for article (PubMed ID: 16227405)
1. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
2. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3).
Bottone FG; Moon Y; Kim JS; Alston-Mills B; Ishibashi M; Eling TE
Mol Cancer Ther; 2005 May; 4(5):693-703. PubMed ID: 15897233
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
Moon Y; Yang H; Kim YB
Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
[TBL] [Abstract][Full Text] [Related]
5. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
[TBL] [Abstract][Full Text] [Related]
7. Growth compensatory role of sulindac sulfide-induced thrombospondin-1 linked with ERK1/2 and RhoA GTPase signaling pathways.
Moon Y; Kim JI; Yang H; Eling TE
Life Sci; 2008 Mar; 82(11-12):591-9. PubMed ID: 18261746
[TBL] [Abstract][Full Text] [Related]
8. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
Bottone FG; Moon Y; Alston-Mills B; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE
Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.
Liggett JL; Choi CK; Donnell RL; Kihm KD; Kim JS; Min KW; Noegel AA; Baek SJ
Biochim Biophys Acta; 2014 Jan; 1840(1):322-31. PubMed ID: 24080406
[TBL] [Abstract][Full Text] [Related]
12. The cyclooxygenase inhibitor indomethacin modulates gene expression and represses the extracellular matrix protein laminin gamma1 in human glioblastoma cells.
Ishibashi M; Bottone FG; Taniura S; Kamitani H; Watanabe T; Eling TE
Exp Cell Res; 2005 Jan; 302(2):244-52. PubMed ID: 15561105
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
Liou JY; Ghelani D; Yeh S; Wu KK
Cancer Res; 2007 Apr; 67(7):3185-91. PubMed ID: 17409426
[TBL] [Abstract][Full Text] [Related]
14. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
[TBL] [Abstract][Full Text] [Related]
16. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
Chiou SK; Hodges A; Hoa N
J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
[TBL] [Abstract][Full Text] [Related]
17. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15.
Kim JS; Baek SJ; Sali T; Eling TE
Mol Cancer Ther; 2005 Mar; 4(3):487-93. PubMed ID: 15767558
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
[TBL] [Abstract][Full Text] [Related]
19. The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB.
Loveridge CJ; MacDonald AD; Thoms HC; Dunlop MG; Stark LA
Oncogene; 2008 Apr; 27(18):2648-55. PubMed ID: 18059344
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest.
Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
Int J Cancer; 2003 Dec; 107(5):844-53. PubMed ID: 14566837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
